1. Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014; 13:83–99.
Article
2. Swanton JK, Fernando K, Dalton CM, et al. Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison. J Neurol Neurosurg Psychiatry. 2006; 77:1070–2.
Article
3. Petzold A, Plant GT. Diagnosis and classification of autoimmune optic neuropathy. Autoimmun Rev. 2014; 13:539–45.
Article
4. Hui AC, Wong RS, Ma R, Kay R. Recurrent optic neuromyelitis with multiple endocrinopathies and autoimmune disorders. J Neurol. 2002; 249:784–5.
Article
5. Yamout B, Usta J, Itani S, Yaghi S. Celiac disease, Behçet, and idiopathic thrombocytopenic purpura in siblings of a patient with multiple sclerosis. Mult Scler. 2009; 15:1368–71.
Article
6. Sahraian MA, Eshaghi A. Concomitant multiple sclerosis and idiopathic thrombocytopenic purpura. Eur J Neurol. 2010; 17:e62–3.
Article
7. Scott LM, Tong W, Levine RL, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med. 2007; 356:459–68.
8. Alemany-Rodríguez MJ, Aladro Y, Amela-Peris R, et al. [Autoimmune diseases and multiple sclerosis]. Rev Neurol. 2005; 40:594–7.
9. Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 2008; 65:727–32.
10. Ahn SM, Kim SS. A case of coexisting neuromyelitis optica in systemic lupus erythematosus. J Korean Ophthalmol Soc. 2013; 54:1469–74.
Article
11. Adoni T, Lino AM, da Gama PD, et al. Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics. Mult Scler. 2010; 16:81–6.
Article
12. Sergio P, Mariana B, Alberto O, et al. Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature. Clin Rheumatol. 2010; 29:1335–8.
Article
13. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007; 6:805–15.
Article
14. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. The Lancet. 1997; 349:1531–6.
Article
15. RABINOWITZ Y, DAMESHEK W. Systemic lupus erytematosus after “idiopathic” thrombocytopenic purpura: a review. Ann Intern Med. 1960; 52:1–28.
16. Hymes K, Blum M, Lackner H, Karpatkin S. Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves’ disease and Hashimoto's thyroiditis. Ann Intern Med. 1981; 94:27–30.
Article
17. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl Med. 2002; 346:995–1008.
Article
18. Sheremata WA, Jy W, Horstman LL, et al. Evidence of platelet activation in multiple sclerosis. J Neuroinflammation. 2008; 5:27.
Article
19. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006; 4:2377–83.
Article
20. Killer HE, Huber A, Portman C, et al. Bilateral non-arteritic anterior ischemic optic neuropathy in a patient with autoimmune thrombocytopenia. Eur J Ophthalmol. 2000; 10:180–2.
Article
21. Bermel RA, Balcer LJ. Optic neuritis and the evaluation of visual impairment in multiple sclerosis. Continuum (Minneap Minn). 2013; 19:1074–86.
Article
22. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet. 2001; 357:1576–82.
Article
23. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998; 51:1219–20.
Article
24. Cusick MF, Libbey JE, Fujinami RS. Multiple sclerosis: autoimmunity and viruses. Curr Opin Rheumatol. 2013; 25:496–501.